{"pmid":32409176,"title":"COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?","text":["COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?","Rev Neurol (Paris)","Aubignat, M","Godefroy, O","32409176"],"journal":"Rev Neurol (Paris)","authors":["Aubignat, M","Godefroy, O"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32409176","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.neurol.2020.05.001","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666897319182729216,"score":9.490897,"similar":[{"pmid":32379918,"title":"Coagulopathy of COVID-19 and antiphospholipid antibodies.","text":["Coagulopathy of COVID-19 and antiphospholipid antibodies.","Recently in the Journal of Thrombosis and Haemostasis, Harzallah and colleagues report the results of antiphospholipid antibody testing in a series of 56 patients with confirmed or suspected SARS-CoV-2 infection.[1] Twenty-five patients were found to be positive for lupus anticoagulants, while five patients had either anticardiolipin or anti-beta2-glycoprotein I antibodies. The isotypes for the anticardiolipin and anti-beta2-glycoprotein I antibodies were reportedly IgG and IgM, although specific antibody titers and details of which were found in combination with a lupus anticoagulant in three overlap patients were not reported.","J Thromb Haemost","Connell, Nathan T","Battinelli, Elisabeth M","Connors, Jean M","32379918"],"abstract":["Recently in the Journal of Thrombosis and Haemostasis, Harzallah and colleagues report the results of antiphospholipid antibody testing in a series of 56 patients with confirmed or suspected SARS-CoV-2 infection.[1] Twenty-five patients were found to be positive for lupus anticoagulants, while five patients had either anticardiolipin or anti-beta2-glycoprotein I antibodies. The isotypes for the anticardiolipin and anti-beta2-glycoprotein I antibodies were reportedly IgG and IgM, although specific antibody titers and details of which were found in combination with a lupus anticoagulant in three overlap patients were not reported."],"journal":"J Thromb Haemost","authors":["Connell, Nathan T","Battinelli, Elisabeth M","Connors, Jean M"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379918","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/jth.14893","topics":["Diagnosis"],"weight":1,"_version_":1666262687574654978,"score":61.779446},{"pmid":32369280,"title":"Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.","text":["Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.","N Engl J Med","Bowles, Louise","Platton, Sean","Yartey, Nada","Dave, Minal","Lee, Kurtis","Hart, Daniel P","MacDonald, Vickie","Green, Laura","Sivapalaratnam, Suthesh","Pasi, K John","MacCallum, Peter","32369280"],"journal":"N Engl J Med","authors":["Bowles, Louise","Platton, Sean","Yartey, Nada","Dave, Minal","Lee, Kurtis","Hart, Daniel P","MacDonald, Vickie","Green, Laura","Sivapalaratnam, Suthesh","Pasi, K John","MacCallum, Peter"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369280","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1056/NEJMc2013656","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138496147914752,"score":56.258774},{"pmid":32425261,"pmcid":"PMC7227496","title":"Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism.","text":["Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism.","*COVID-19 pneumonia could be associated with an increased risk of venous thrombosis.*Antiphospholipid antibodies might be involved in thrombosis in COVID-19 patients.*Prevalence of antiphospholipid antibodies in COVID-19 and venous thrombosis was low.","Thromb Res","Galeano-Valle, F","Oblitas, C M","Ferreiro-Mazon, M M","Alonso-Munoz, J","Del Toro-Cervera, J","Demelo-Rodriguez, P","32425261"],"abstract":["*COVID-19 pneumonia could be associated with an increased risk of venous thrombosis.*Antiphospholipid antibodies might be involved in thrombosis in COVID-19 patients.*Prevalence of antiphospholipid antibodies in COVID-19 and venous thrombosis was low."],"journal":"Thromb Res","authors":["Galeano-Valle, F","Oblitas, C M","Ferreiro-Mazon, M M","Alonso-Munoz, J","Del Toro-Cervera, J","Demelo-Rodriguez, P"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425261","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.thromres.2020.05.017","topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667352728760745984,"score":54.809288},{"pmid":32324958,"title":"Lupus anticoagulant is frequent in patients with Covid-19.","text":["Lupus anticoagulant is frequent in patients with Covid-19.","Patients hospitalized for Covid-19 severe infection are more prone to excessive coagulation activation leading to thrombotic events. Tang et al.1 discussed the importance of high D-dimer and Fibrin degradation product level to determine the patient prognostic and the risk of thrombosis. However they did not look at lupus anticoagulant (LAC). Zhang et al. described, three cases of thrombosis associated with antiphospholipid antibodies represented by anticardiolipin (aCL) and anti-beta2-glycoprotein I (abeta2GPI)2. No lupus anticoagulant was detected in any of the patients.","J Thromb Haemost","Harzallah, Ines","Debliquis, Agathe","Drenou, Bernard","32324958"],"abstract":["Patients hospitalized for Covid-19 severe infection are more prone to excessive coagulation activation leading to thrombotic events. Tang et al.1 discussed the importance of high D-dimer and Fibrin degradation product level to determine the patient prognostic and the risk of thrombosis. However they did not look at lupus anticoagulant (LAC). Zhang et al. described, three cases of thrombosis associated with antiphospholipid antibodies represented by anticardiolipin (aCL) and anti-beta2-glycoprotein I (abeta2GPI)2. No lupus anticoagulant was detected in any of the patients."],"journal":"J Thromb Haemost","authors":["Harzallah, Ines","Debliquis, Agathe","Drenou, Bernard"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324958","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jth.14867","topics":["Treatment"],"weight":1,"_version_":1666138493881942016,"score":53.066498},{"pmid":32268022,"pmcid":"PMC7161262","title":"Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.","text":["Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.","N Engl J Med","Zhang, Yan","Xiao, Meng","Zhang, Shulan","Xia, Peng","Cao, Wei","Jiang, Wei","Chen, Huan","Ding, Xin","Zhao, Hua","Zhang, Hongmin","Wang, Chunyao","Zhao, Jing","Sun, Xuefeng","Tian, Ran","Wu, Wei","Wu, Dong","Ma, Jie","Chen, Yu","Zhang, Dong","Xie, Jing","Yan, Xiaowei","Zhou, Xiang","Liu, Zhengyin","Wang, Jinglan","Du, Bin","Qin, Yan","Gao, Peng","Qin, Xuzhen","Xu, Yingchun","Zhang, Wen","Li, Taisheng","Zhang, Fengchun","Zhao, Yongqiang","Li, Yongzhe","Zhang, Shuyang","32268022"],"journal":"N Engl J Med","authors":["Zhang, Yan","Xiao, Meng","Zhang, Shulan","Xia, Peng","Cao, Wei","Jiang, Wei","Chen, Huan","Ding, Xin","Zhao, Hua","Zhang, Hongmin","Wang, Chunyao","Zhao, Jing","Sun, Xuefeng","Tian, Ran","Wu, Wei","Wu, Dong","Ma, Jie","Chen, Yu","Zhang, Dong","Xie, Jing","Yan, Xiaowei","Zhou, Xiang","Liu, Zhengyin","Wang, Jinglan","Du, Bin","Qin, Yan","Gao, Peng","Qin, Xuzhen","Xu, Yingchun","Zhang, Wen","Li, Taisheng","Zhang, Fengchun","Zhao, Yongqiang","Li, Yongzhe","Zhang, Shuyang"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32268022","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1056/NEJMc2007575","topics":["Case Report"],"weight":1,"_version_":1666138491901181952,"score":50.611004}]}